Описание деятельности
Medios AG, along with its subsidiaries Medios Pharma GmbH and Medios Manufaktur GmbH, has positioned itself in the specialty pharma segment as the go-to source for expertise and solutions. It brings together individual market players in a network of cooperating partners. Specialty pharmaceutical drugs are medications for patients with rare and/or chronic illnesses (for example, cancer, autoimmune diseases, and infectious diseases) that require lengthy and expensive treatment. Medios AG buys, sells and manages investments of innovative companies. The company aims to establish a strategic investment portfolio and to support its governance.
Правление & Наблюдательный совет
| Исполнительный директор |
| Matthias Gärtner |
| Правление |
| Falk Neukirch, Christoph Prußeit, Mi-Young Miehler, Constantijn van Rietschoten |
| Наблюдательный совет |
| Dr. Yann Samson, Joachim Messner, Dr. Anke Nestler, Klaus Buß |
Данные компании
| Имя: |
Medios AG |
| Адрес: |
Friedrichstraße 113a,D-10117 Berlin |
| Телефон: |
+49 30 232 566 800 |
| Факс: |
+49 30 232 566 800 |
| E-mail: |
info@medios.ag
|
| Интернет: |
www.medios.ag |
| Индустрия: |
Healthcare |
| Сектор: |
Pharmaceutical Industry |
| Подсектор: |
Pharmaceuticals |
| Конец финансового года: |
31.12 |
| Акции в свободном обращении: |
58.50% |
| Дата IPO: |
15.07.1999 |
Связи с инвесторами
| Имя: |
Claudia Nickolaus |
| IR телефон: |
+49 30 232 566 800 |
| IR-факс: |
- |
| IR e-mail: |
ir@medios.ag
|
